[HTML] mdpi.com

[HTML][HTML] PLGA nanoparticle-based formulations to cross the blood–brain barrier for drug delivery: From R&D to cGMP

K Zhi, B Raji, AR Nookala, MM Khan, XH Nguyen… - Pharmaceutics, 2021 - mdpi.com
The blood–brain barrier (BBB) is a natural obstacle for drug delivery into the human brain,
hindering treatment of central nervous system (CNS) disorders such as acute ischemic …
被引用次数：71 相关文章

Plga nanoparticle-based formulations to cross the blood-brain barrier for drug delivery: From r&d to cgmp

K Zhi, B Raji, AR Nookala, MM Khan… - …, 2021 - digitalcommons.memphis.edu
The blood-brain barrier (BBB) is a natural obstacle for drug delivery into the human brain,
hindering treatment of central nervous system (CNS) disorders such as acute ischemic …

PLGA Nanoparticle-Based Formulations to Cross the Blood–Brain Barrier for Drug Delivery: From R&D to cGMP

K Zhi, B Raji, AR Nookala, MM Khan… - …, 2021 - search.proquest.com
The blood–brain barrier (BBB) is a natural obstacle for drug delivery into the human brain,
hindering treatment of central nervous system (CNS) disorders such as acute ischemic …
[PDF] semanticscholar.org

[PDF][PDF] PLGA Nanoparticle-Based Formulations to Cross the Blood–Brain Barrier for Drug Delivery: From R&D to cGMP. Pharmaceutics 2021, 13, 500

K Zhi, B Raji, AR Nookala, MM Khan, XH Nguyen… - 2021 - pdfs.semanticscholar.org
The blood–brain barrier (BBB) is a natural obstacle for drug delivery into the human brain,
hindering treatment of central nervous system (CNS) disorders such as acute ischemic …

PLGA Nanoparticle-Based Formulations to Cross the Blood-Brain Barrier for Drug Delivery: From R&D to cGMP

K Zhi, B Raji, AR Nookala, MM Khan… - …, 2021 - pubmed.ncbi.nlm.nih.gov
The blood-brain barrier (BBB) is a natural obstacle for drug delivery into the human brain,
hindering treatment of central nervous system (CNS) disorders such as acute ischemic …

PLGA Nanoparticle-Based Formulations to Cross the Blood–Brain Barrier for Drug Delivery: From R&D to cGMP.

K Zhi, B Raji, AR Nookala, MM Khan… - …, 2021 - search.ebscohost.com
The blood–brain barrier (BBB) is a natural obstacle for drug delivery into the human brain,
hindering treatment of central nervous system (CNS) disorders such as acute ischemic …
[PDF] academia.edu

[PDF][PDF] PLGA Nanoparticle-Based Formulations to Cross the Blood–Brain Barrier for Drug Delivery: From R&D to cGMP. Pharmaceutics 2021, 13, 500

K Zhi, B Raji, AR Nookala, MM Khan, XH Nguyen… - 2021 - academia.edu
The blood–brain barrier (BBB) is a natural obstacle for drug delivery into the human brain,
hindering treatment of central nervous system (CNS) disorders such as acute ischemic …

PLGA Nanoparticle-Based Formulations to Cross the Blood-Brain Barrier for Drug Delivery: From R&D to cGMP.

K Zhi, B Raji, AR Nookala, MM Khan, XH Nguyen… - …, 2021 - europepmc.org
The blood–brain barrier (BBB) is a natural obstacle for drug delivery into the human brain,
hindering treatment of central nervous system (CNS) disorders such as acute ischemic …

PLGA Nanoparticle-Based Formulations to Cross the Blood–Brain Barrier for Drug Delivery: From R&D to cGMP

K Zhi, B Raji, AR Nookala, MM Khan… - …, 2021 - scholarworks.utrgv.edu
The blood–brain barrier (BBB) is a natural obstacle for drug delivery into the human brain,
hindering treatment of central nervous system (CNS) disorders such as acute ischemic …
[HTML] nih.gov

[HTML][HTML] PLGA Nanoparticle-Based Formulations to Cross the Blood–Brain Barrier for Drug Delivery: From R&D to cGMP

K Zhi, B Raji, AR Nookala, MM Khan, XH Nguyen… - …, 2021 - ncbi.nlm.nih.gov
The blood–brain barrier (BBB) is a natural obstacle for drug delivery into the human brain,
hindering treatment of central nervous system (CNS) disorders such as acute ischemic …